Isolation, characterization and in silico study of propenamide alkaloids from Hymenoepmecis bicolor poison against active μ-opioid receptor

Some insects produce venoms to defend against predators and directly interact with opioid receptors. In the present study, it was identified two alkaloids in the wasp venom species Hymenoepimecis bicolor. It was demonstrated that these could act as potential inhibitors of opioid receptors through th...

Full description

Saved in:
Bibliographic Details
Published in:Journal of biomolecular structure & dynamics Vol. 41; no. 24; pp. 14621 - 14637
Main Authors: Marques da Fonseca, Aluísio, Freire da Silva, Ananias, Barbosa da Silva, Francisco Lennon, Caluaco, Bernardino Joaquim, Gaieta, Eduardo Menezes, Nunes da Rocha, Matheus, Colares, Regilany Paulo, Sobczak, Jober Fernando, Marinho, Gabrielle Silva, dos Santos, Hélcio Silva, Marinho, Emmanuel Silva
Format: Journal Article
Language:English
Published: England Taylor & Francis 29.12.2023
Subjects:
ISSN:0739-1102, 1538-0254, 1538-0254
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Some insects produce venoms to defend against predators and directly interact with opioid receptors. In the present study, it was identified two alkaloids in the wasp venom species Hymenoepimecis bicolor. It was demonstrated that these could act as potential inhibitors of opioid receptors through their robust affinity to the receptors. The interaction profile was given to opioid receptors (μOR), with 60% of targets similar to alkaloid 1, with 0.25 probability, and 46.7% of targets similar to alkaloid 2, with a probability 0.17 of affinity as a target, which is considered signaling macromolecules and can mediate the most potent analgesic and addictive properties of opiate alkaloids. Notably, both alkaloids showed −7.6 kcal/mol affinity to the morphine agonies through six residues, Gly124, Asp147, Trp293, Ile296, Ile322, and Tyr326. These observations suggest further research on opioid receptors using in vitro studies of possible therapeutic applications. Communicated by Ramaswamy H. Sarma
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0739-1102
1538-0254
1538-0254
DOI:10.1080/07391102.2023.2183043